Market Place
Sourcing Support
Roche and KeChow Reach a Cooperation Agreement
20 Aug 2021 //
PRNEWSWIRE
FDA Approves Atezolizumab Plus Cobimetinib and Vemurafenib for Advanced Melanoma
30 Jul 2020 //
CANCERNETWORK
Roche`s Tecentriq, on top of targeted drugs, stalls melanoma
26 Apr 2020 //
FIERCE PHARMA
Roche`s phase III IMspire150 study of Tecentriq plus Cotellic & Zelboraf
13 Dec 2019 //
PHARMABIZ
HSE reimburses Braftovi combo
23 Aug 2019 //
PHARMA TIMES
Meet the protein responsible for nearly $100B in cancer drug deals
17 Aug 2019 //
BIOPHARMADIVE
Roche/Exelixis` Cotellic fizzles in pivotal melanoma study
21 Jun 2019 //
ENDPTS
NICE recommends Pierre Fabre`s Braftovi in BRAF V600-mutated advanced melanoma
22 Jan 2019 //
PHARMA FILE
Novartis wins key adjuvant Taf/Mek approval in Europe
29 Aug 2018 //
PM LIVE
Array scores FDA nod for Braftovi, Mektovi melanoma combo
28 Jun 2018 //
FIERCE PHARMA
Pierre Fabre-Array BioPharma Announce Addl Results of Encorafenib & Binimetinib
04 Jun 2018 //
BUSINESSWIRE
Array BioPharma Touts Phase III Results for Melanoma Therapy
22 Mar 2018 //
BIOSPACE
Array MEK/BRAF combo beats out Roche rival in PhIII melanoma OS showdown
07 Feb 2018 //
ENDPTS
Roche gives free access to cancer drug after Greek government altercation
08 Nov 2017 //
BIOSPECTRUM
FDA Approves Genentech`s Zelboraf, First-Ever Drug to treat Rare Blood Disease
08 Nov 2017 //
BIOSPACE
FDA approves new drug Zelboraf for Erdheim-Chester disease
06 Nov 2017 //
MEDICAL
Roche shares hit by trial flops, fears over biosimilar defense
12 Sep 2017 //
REUTERS
Roche extends losing streak with a setback for Zelboraf as Novartis combo
11 Sep 2017 //
ENDPTS
Roche to present results from number of studies across 18 approved & Inves.
04 Sep 2017 //
PHARMABIZ
Plexxikon targets Novartis` Tafinlar in cancer med dispute
09 Aug 2017 //
FIERCE PHARMA
Novartis wins CHMP nod for drug combo against some lung cancers
25 Feb 2017 //
REUTERS
Array BioPharma Has a Potential Blockbuster Melanoma Drug On Its Hands
11 Feb 2017 //
BIOSPACE
Roche’s Genentech taps A-lister Morgan Freeman for cancer PSA
09 Dec 2016 //
FIERCE PHARMA
Roche pushes Tecentriq combos into PhIII melanoma trials
07 Nov 2016 //
PHARMATIMES
NICE nods for Tagrisso, Cimzia and Zepatier
27 Oct 2016 //
PHARMATIMES
Novartis` show superior survival benefit in advanced melanoma in phase III
11 Oct 2016 //
PHARMABIZ
NICE rejects Roche’s melanoma combo
07 Sep 2016 //
PHARMATIMES
Roche skin cancer drugs `too expensive`, says UK cost agency
17 Jun 2016 //
REUTERS
ZELBORAF- Risk of Radiation Sensitization or Radiation Recall Reaction
22 Dec 2015 //
HEALTH CANADA
Amgen slaps $178K price on rare new leukemia drug Blincyto
01 Dec 2015 //
FIERCE PHARMA MARKETING
Bump in the road slows momentum for BMS` Opdivo
30 Nov 2015 //
PM LIVE
EU approves Roche`s Cotellic in combo therapy against skin cancer
26 Nov 2015 //
REUTERS
Roche buoyed by early data on atezolizumab in advanced melanoma
24 Nov 2015 //
REUTERS
Daiichi Sankyo and Plexxikon get FDA nod for melanoma combination
11 Nov 2015 //
FIERCE PHARMA ASIA
Diplomat to Dispense Melanoma Drug COTELLIC® in Combination with ZELBORAF®
11 Nov 2015 //
PR NEWS WIRE
Roche Announces Strategic Plan with Seven Trial Readouts Expected in Next 2 Year
05 Nov 2015 //
BIOSPACE
Genentech, Exelixis score another PhIII success for cobimetinib
07 Oct 2015 //
FIERCE BIOTECH
Roche says data shows Cotellic combination therapy effective
06 Oct 2015 //
REUTERS
Combination Therapy Continues to Show Survival Benefit Over Vemurafenib
30 Sep 2015 //
FIRST WORD PHARMA
Roche CEO: Despite China worries, emerging markets will continue to deliver growth
10 Sep 2015 //
FIERCE PHARMA
Roche wins first approval for skin cancer drug Cotellic
31 Aug 2015 //
PM LIVE
Exelixis` melanoma combo bags first global approval
29 Aug 2015 //
PHARMA TIMES
Roche open to alliances in hunt for cancer drug combinations
01 Apr 2015 //
REUTERS
Roche Says Swiss Franc`s Surge May Erode Profit Growth This Year
29 Jan 2015 //
BLOOMBERG
Get Ready to Negotiate, Drugmakers: Payers are Armed for Drug-Pricing Battle
24 Dec 2014 //
FIERCE PHARMA
